HOYA CORPORATION PENTAX TOKYO OFFICE
Manufacturer adverse-event records for HOYA CORPORATION PENTAX TOKYO OFFICE come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2014–2026 · heavy-book · quiet Death-code · injury-light
Injury-mix signature
HOYA CORPORATION PENTAX TOKYO OFFICE is lighter on Injury codes
Injury-coded event_type share is 1.3% (injury-light tercile) beside 0.06% Death-coded (quiet). Volume band: heavy.
What the Injury-mix reading shows for HOYA CORPORATION PENTAX TOKYO OFFICE
The standout signal for HOYA CORPORATION PENTAX TOKYO OFFICE is Injury-mix: 1.3% Injury-coded (injury-light) beside 0.06% Death-coded, on a heavy-book footprint.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair HOYA CORPORATION PENTAX TOKYO OFFICE with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Malfunction at 46,463 (98.5% of event_type total). Peak single-year volume reaches 12,912 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.